Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COAST: Prophylactic EPO and Iron for Acute Mountain Sickness
NCT05734716Phase 4Completed
- Sponsor
- University of Oregon
- Start
- Feb 2021
- Primary completion
- Aug 2022
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of erythropoietin, iron sucrose in acute mountain sickness (AMS), sponsored by University of Oregon. Started Feb 2021; status: completed.
02
Drugs
erythropoietiniron sucrose
03
Conditions
acute mountain sickness (AMS)
Beyond the preview
Go deeper on NCT05734716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05734716.